The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Triapin 5 mg/5 mg prolonged release tablets

IMED Healthcare Ltd.PPA1463/098/001

Main Information

Trade NameTriapin 5 mg/5 mg prolonged release tablets
Active SubstancesFelodipine
Dosage FormProlonged-release tablet
Licence HolderIMED Healthcare Ltd.
Licence NumberPPA1463/098/001

Group Information

ATC CodeC09BB ACE inhibitors and calcium channel blockers
C09BB05 ramipril and felodipine


License statusAuthorised
Licence Issued15/08/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0032-012-024
Interchangeable List DocumentPDF of Interchangeable List
« Back